Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin Supplementation for Pregnancy Indicated Risk Reduction in Nulliparas (ASPIRIN): Neurodevelopmental Follow-up Trial

NCT04888377 is registered in ClinicalTrials.gov with NICHD Global Network for Women's and Children's Health as lead sponsor.

NCT NCT04888377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin Supplementation for Pregnancy Indicated Risk Reduction in Nulliparas (ASPIRIN): Neurodevelopmental Follow-up Trial
Lead sponsor
NICHD Global Network for Women's and Children's Health
Phase
Observational
Overall status
Completed
Start date
September 1, 2021
Completion date
June 15, 2022
Enrollment
666 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

neurodevelopmental abnormality